HRMY

Harmony Biosciences Holdings, Inc. · NASDAQ

Sector Health Technology
Industry Pharmaceuticals: Major
Website armonybiosciences.com
Employees(FY) 200
ISIN US4131971040

Performance

+3.24%

-2.52%

-7.42%

+14.91%

+5.48%

YTD

+19.54%

Profile

Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, focuses on developing and commercializing therapies for patients with rare and other neurological diseases in the United States. It offers WAKIX (pitolisant), a molecule with a novel mechanism of action for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony Biosciences II, Inc. and changed its name to Harmony Biosciences Holdings, Inc. in February 2020. Harmony Biosciences Holdings, Inc. was incorporated in 2017 and is headquartered in Plymouth Meeting, Pennsylvania.

Advanced Technical Analysis

Technical Analysis of HRMY 2024-11-22

The stock indicators reflect a neutral sentiment overall, with the Moving Average Score at 50 indicating a balanced trend, while the Oscillators Score of 46 and Technical Score of 48 suggest a slight bearish inclination. This combination implies that while there is no strong momentum in either direction, caution may be warranted as the scores ho...

Technical Scores and Rating

Moving Average Score

Oscillator Score

Technical Rating

Stock Analysis of HRMY

Stock Rank

Recent News & Updates

2024-11-21 08:05
HARMONY BIOSCIENCES TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES(PR Newswire)
2024-11-20 19:05
HARMONY BIOSCIENCES TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES(Prnewswire)
2024-11-12 19:00
HRMY: Rating increased to a BUY(Argus Research)
2024-11-05 19:00
HRMY: Lowering target price to $35.00(Argus Research)
2024-11-05 05:53
There May Be Some Bright Spots In Harmony Biosciences Holdings' (NASDAQ:HRMY) Earnings(Simply Wall St.)
2024-11-01 11:14
Earnings Beat: Harmony Biosciences Holdings, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models(Simply Wall St.)
2024-11-01 09:40
Are Investors Undervaluing Harmony Biosciences (HRMY) Right Now?(Zacks)
2024-10-31 11:40
HRMY vs. REGN: Which Stock Is the Better Value Option?(Zacks)
2024-10-31 08:28
Harmony Biosciences Holdings Third Quarter 2024 Earnings: Beats Expectations(Simply Wall St.)
2024-10-30 22:30
Harmony Biosciences Holdings, Inc. Announces Pricing of Public Offering of Common Stock by Selling Shareholders(PR Newswire)
2024-10-30 10:30
Harmony Biosciences Holdings, Inc. Announces Pricing of Public Offering of Common Stock by Selling Shareholders(Prnewswire)
2024-10-30 05:04
Harmony Biosciences Holdings Launches Secondary Common Stock Offering(MT Newswires)
2024-10-30 03:06
Harmony Biosciences Holdings Inc (HRMY) Q3 2024 Earnings Call Highlights: Strong Revenue Growth ...(GuruFocus.com)
2024-10-30 02:26
Q3 2024 Harmony Biosciences Holdings Inc Earnings Call(Thomson Reuters StreetEvents)
2024-10-29 18:00
Axonis Therapeutics Announces $115 Million Series A Financing(Prnewswire)
2024-10-29 17:15
Harmony Biosciences Holdings, Inc. Announces Commencement of Proposed Public Offering of Common Stock by Selling Shareholders(PR Newswire)
2024-10-29 16:00
Harmony Biosciences (HRMY) Q3 2024 Earnings Call Transcript(Motley Fool)
2024-10-29 08:40
Harmony Biosciences Holdings, Inc. (HRMY) Q3 Earnings and Revenues Surpass Estimates(Zacks)
2024-10-29 08:09
Harmony Biosciences Holdings Q3 Adjusted Earnings, Net Product Revenue Increase(MT Newswires)
2024-10-29 07:30
HARMONY BIOSCIENCES REPORTS STRONG THIRD QUARTER 2024 FINANCIAL RESULTS AND HIGHLIGHTS CATALYST-RICH, LATE-STAGE PIPELINE POISED TO DELIVER ONE OR MORE NEW LAUNCHES EVERY YEAR OVER NEXT FIVE YEARS(PR Newswire)
2024-10-29 05:15
Harmony Biosciences Holdings, Inc. Announces Commencement of Proposed Public Offering of Common Stock by Selling Shareholders(Prnewswire)
2024-10-28 21:27
Harmony Bio, The No. 1 Biotech Stock, Surged On Its 'High-Quality' Beat(Yahoo Finance)
2024-10-28 19:30
HARMONY BIOSCIENCES REPORTS STRONG THIRD QUARTER 2024 FINANCIAL RESULTS AND HIGHLIGHTS CATALYST-RICH, LATE-STAGE PIPELINE POISED TO DELIVER ONE OR MORE NEW LAUNCHES EVERY YEAR OVER NEXT FIVE YEARS(Prnewswire)
2024-10-23 10:02
Analysts Estimate GSK (GSK) to Report a Decline in Earnings: What to Look Out for(Zacks)
2024-10-22 10:01
Harmony Biosciences Holdings, Inc. (HRMY) Earnings Expected to Grow: Should You Buy?(Zacks)
2024-10-16 08:05
HARMONY BIOSCIENCES TO REPORT THIRD QUARTER 2024 FINANCIAL RESULTS ON OCTOBER 29, 2024(PR Newswire)
2024-10-15 20:05
HARMONY BIOSCIENCES TO REPORT THIRD QUARTER 2024 FINANCIAL RESULTS ON OCTOBER 29, 2024(Prnewswire)
2024-10-14 09:51
Wall Street Analysts Favor Harmony Biosciences Holdings, Inc. (HRMY) for Growth(Insider Monkey)
2024-10-11 12:14
Is Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) The Top Stock With Improving Technical Ratings According To Piper Sandler?(Insider Monkey)
2024-10-09 17:02
Harmony Biosciences Holdings Inc (HRMY) Q2 2024 Earnings Call Highlights: Strong Revenue Growth ...(GuruFocus.com)

Page 1 of 9

previousnext

Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment. Kavout and its partners are participants in a number of affiliate advertising programs. As an Amazon Associate, Kavout or its partners earn from qualifying purchases from affiliate links. We also participate in other affiliate and advertising programs that provide a means for us to earn advertising fees by advertising and linking to third-party websites.